Maravai Lifesciences Holdings (MRVI) Debt Ratio (2020 - 2026)

Maravai Lifesciences Holdings' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.35 for Q1 2026.

• In Q1 2026, Debt Ratio rose 12.44% year-over-year to 0.35; the TTM figure through Mar 2026 stood at 0.35 (up 12.44% YoY), while the FY2025 annual figure was 0.38, up 26.67% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.35, down from 0.38 in the prior quarter.
• The five-year high for Debt Ratio was 0.41 in Q3 2024, with the low at 0.23 in Q4 2022.
• The 5-year median for Debt Ratio is 0.33 (2025), against an average of 0.32.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio plunged 32.4% in 2023, then soared 76.3% in 2024.
• Maravai Lifesciences Holdings' Debt Ratio stood at 0.23 in 2022, then surged by 54.06% to 0.36 in 2023, then fell by 16.05% to 0.3 in 2024, then advanced by 26.67% to 0.38 in 2025, then slipped by 8.74% to 0.35 in 2026.
• Business Quant data shows MRVI's Debt Ratio at 0.35 in Q1 2026, 0.38 in Q4 2025, and 0.34 in Q3 2025.